As Vaccine Approvals Loom, U.S. Funds A Back-Up Plan For Delivery
As the U.S. prepares for what will likely be the largest vaccination program in its history, the Trump administration plans to loan $590 million to a Connecticut company with a novel technology.
As the nation gears up for a massive vaccination effort, the Trump administration is doubling down on a novel, unproven injection device by providing more than half a billion dollars in government financing for something that is still awaiting Food and Drug Administration approval.
Later today, the U.S. International Development Finance Corp, or DFC, is expected to announce that it has extended a $590 million loan to ApiJect Systems America, NPR has learned. The Connecticut company makes a disposable injection device that it says can be mass produced to deliver vaccines and medications around the world.
The single-use, self-contained devices are designed to be an alternative to traditional vials and syringes. "This is going
